Sort
17,288 grants matching “multiple sclerosis”
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,016,407Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Adaptive changes of the ground squirrel retina during hibernation
$1,015,192Wei Li · National Eye Institute · ZIA · FY2022 · EY
CNS Damage from Theiler's Virus Persistence: MS Model
$1,014,791Northwestern University · P01 · FY2003 · NS
IMMUNOGENETICS OF DEMYELINATION
$1,013,312Mayo Clinic · P01 · FY2004 · NS
CNS Damage from Theiler's Virus Persistence: MS Model
$1,013,024Northwestern University · P01 · FY2004 · NS
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,010,907Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$1,010,176Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
molecular mechanisms of the blood brain barrier function and regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2022 · NS
Molecular Mechanisms of the Blood Brain Barrier Function and Regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2025 · NS
Molecular Mechanisms of the Blood Brain Barrier Function and Regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2023 · NS
molecular mechanisms of the blood brain barrier function and regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2021 · NS
molecular mechanisms of the blood brain barrier function and regulation
$1,009,297Chenghua Gu · Harvard Medical School · R35 · FY2020 · NS
Postmortem Pathology
$1,008,987David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$1,008,085Tracy M Handel · University Of California, San Diego · U01 · FY2010 · GM
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$1,007,803Justin Kawika Ichida · University Of Southern California · R01 · FY2022 · NS
Role of Microglia somatic variants in Neurodegenerative diseases
$1,003,889Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2019 · NS
IMMUNOGENETICS OF DEMYELINATION
$1,003,784Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2003 · NS
Genetic Architecture of Pure Alzheimer's Disease and Mixed Pathology
$1,003,149Shubhabrata Mukherjee · University Of Washington · R01 · FY2025 · AG
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
$1,001,898Upendra Marathi · 7 Hills Pharma, Llc · R42 · FY2019 · CA
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$1,001,549Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Genetic Architecture of Pure Alzheimer's Disease and Mixed Pathology
$1,001,520Shubhabrata Mukherjee · University Of Washington · R01 · FY2023 · AG
Development of a first-in-class therapeutic for producing 'on-demand' voiding
$1,001,467Karl B Thor · Dignify Therapeutics, Llc · R44 · FY2018 · DK
Safe and effective anti CD154 antibodies for therapeutic intervention
$1,000,000Jay L Rothstein · Immunext, Inc. · R44 · FY2015 · AI
Development of a novel accurate therapy for multiple sclerosis
$1,000,000Gaddiel Galarza-Munoz · Autoimmunity Biologic Solutions, Inc. · R42 · FY2022 · AI
Bridging Interventional Development Gaps (BrIDGs)
$1,000,000Leidos Biomedical Research, Inc. · N01 · FY2012 · CA